Citryll

Targeting neutrophil extracellular traps for autoimmune diseases

placeAmsterdam, North Holland, Netherlands calendar_todayFounded 2015 groups19 employees language citryll.com

Social engagement

Social engagement: 3.5K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

13 investors on record; lead investors include Modiquest, BOM, BrightGene, Curie Capital.

Investor typeCountShare
Venture capital862%
Other / undisclosed538%

Recent activity

18 Jun 2026
Event
ETs webinar on EI in immune-mediated inflammatory diseases (IMIDs)
15 Jun 2026
Event
extracellular traps (ETs) in immune-mediated inflammatory diseases webinar
8 Jun 2026
Event
ETs webinar on EES in immune-mediated inflammatory diseases
Coming soon